VALERION THERAPEUTICS Overview
Company Headquarters: Concord, US
Founded: 2007
Workforce: ~50
Company Working: Valerion Therapeutics (Valerion) a part of the Alopexx Enterprises, is an emerging biotech company, involved in developing product category for rare diseases. Valerion develops chemical conjugation products by utilizing enzymes, proteins, oligonucleotides, and more; to treat several diseases with limited or no current therapeutic options.
Strategy
Valerion focuses on the development of biotherapeutics for orphan genetic diseases. It utilizes various substances such as enzymes, proteins, oligonucleotides, among others, for drug development.



